Lexaria Bioscience Corporation (LEXXW)
NASDAQ
Fin d'année 31 Août 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -190.141 | -109.075 | -249.442 | -160.556 | -153.88 | -50.04 | -68.9 | -122.103 |
Return on Equity (%) | -326.613 | -130.882 | -255.974 | -168.061 | -170.314 | -51.808 | -70.245 | -129.267 |
Return on Invested Capital (%) | -319.392 | -128.232 | -255.974 | -169.455 | -56.973 | -74.328 | -71.844 | -128.386 |
Operating Margin (%) | -3073.171 | -3004.688 | -1526.328 | -1872.973 | -1063.542 | -576.584 | -2895.294 | -2970.354 |
Net Profit Margin (%) | -2963.415 | -2920.313 | -1524.018 | -1846.396 | -1102.604 | -554.683 | -2850.588 | -2949.115 |
Book Value Per Share | 0.001 | 0.046 | 0.03 | 0.028 | 0.024 | 2.218 | 1.201 | 0.274 |
Earnings Per Share | -0.024 | -0.032 | -0.087 | -0.052 | -0.047 | -0.703 | -1.222 | -0.824 |
Cash Per Share | 0.002 | 0.043 | 0.023 | 0.016 | 0.014 | 1.907 | 0.977 | 0.167 |
Working Capital Per Share | 0.001 | 0.046 | 0.03 | 0.021 | 0.019 | 2.146 | 1.14 | 0.239 |
Operating Profit Per Share | N/A | 0.001 | 0.005 | 0.003 | 0.003 | 0.116 | 0.031 | 0.024 |
EBIT Per Share | -0.025 | -0.033 | -0.087 | -0.053 | -0.045 | -0.731 | -1.241 | -0.83 |
EBITDA Per Share | -0.025 | -0.033 | -0.087 | -0.053 | -0.045 | -0.731 | -1.241 | -0.83 |
Free Cash Flow Per Share | -0.023 | -0.032 | -0.086 | -0.043 | -0.048 | -0.709 | -1.191 | -0.826 |
Fin d'année 31 Août 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Fin d'année 31 Août 2023 | Août 2022 | Nov 2022 | Fév 2023 | Mai 2023 | Août 2023 | Nov 2023 | Fév 2024 | Mai 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1751.485 | N/A | N/A | N/A | -784.768 | N/A | N/A |
Net Profit Margin (%) | N/A | -1738.614 | N/A | N/A | N/A | -780.795 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 0 |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 0 |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales